3-H-[1,2]Dithiole as a New Anti-Trypanosoma cruzi Chemotype: Biological and Mechanism of Action Studies
The current pharmacological Chagas disease treatments, using Nifurtimox or Benznidazole, show limited therapeutic results and are associated with potential side effects, like mutagenicity. Using random screening we have identified new chemotypes that were able to inhibit relevant targets of the Tryp...
Main Authors: | Marcos Couto, Carina Sánchez, Belén Dávila, Valentina Machín, Javier Varela, Guzmán Álvarez, Mauricio Cabrera, Laura Celano, Beatriz Aguirre-López, Nallely Cabrera, Marieta Tuena de Gómez-Puyou, Armando Gómez-Puyou, Ruy Pérez-Montfort, Hugo Cerecetto, Mercedes González |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/20/8/14595 |
Similar Items
-
Purification and Partial Characterization of Trypanosoma cruzi Triosephosphate Isomerase
by: Bourguignon SC, et al.
Published: (1998-01-01) -
Novel and Selective Rhipicephalus microplus Triosephosphate Isomerase Inhibitors with Acaricidal Activity
by: Luiz Saramago, et al.
Published: (2018-08-01) -
Identification of the critical residues responsible for differential reactivation of the triosephosphate isomerases of two trypanosomes
by: Monica Rodríguez-Bolaños, et al.
Published: (2016-01-01) -
Phenotypic and Target-Directed Screening Yields New Acaricidal Alternatives for the Control of Ticks
by: Tatiana Saporiti, et al.
Published: (2022-12-01) -
Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Trypanosoma cruzi Infection in the BALB/c Mice Model of Experimental Chagas Disease
by: Luciana L. Soprano, et al.
Published: (2022-01-01)